throbber
Brit. ]. Ophthal. (1973) 57, 852
`
`Histology of the lacrimal gland in
`keratoconjunctivitis sicca
`
`JOHN WILLIAMSON*, A. A. M. GIBSON**, T. WILSONT,
`J. V. FORRESTER*, K. WHALEY_’;, AND W. C. DICKI
`
`From the *Eye Department, Southern General Hospital, The **Department of Pathology, Tor/chill
`Hospital, The 'l'Tennent Institute of Ophthalmology, University Department of Ophthalmology,
`Western Infirmary, and The ,’_r_Centre for Rheumatic Diseases, University Department of Medicine,
`Royal Infirmary, Glasgow
`
`The histology of Sjogren’s syndrome, which is defined as keratoconjunctivitis sicca (KCS)
`with xerostomia and rheumatoid arthritis, for the purpose of this communication, has
`been studied post mortem either in single cases or in series of not more than three patients
`(Sjogren, I933; Holm, 1949; Allington, 1950; Bohm, 1950; Ellman, Weber, and Goodier,
`1951; Morgan and Raven, 1952; Cardell and Gurling, 1954; Szanto, Farkas, and Gyulai
`I957; Funatsu and Eguchi, I957; Bucher and Reid, 1959; Bain, 1960; Bloch, Buchanan,
`Mlohl, and Bunim, 1965).
`The lacrimal and salivary glands, and the mucous glands of the respiratory tract,
`mouth, and upper oesophagus are typically involved. However, most of the observa-
`tions on lacrimal gland structure were recorded in severe cases of KCS and in patients
`who had died as a result of the severe complications of arthritis or another connective
`tissue disease. The primary purpose of this study was to investigate the histology of the
`lacrimal gland in patients currently suffering from KCS.
`Patients with KCS and xerostomia, but no evidence of connective tissue disease, may
`be classified as suffering from the “sicca syndrome” (Bloch and others, 1965). Lacrimal
`gland tissue from such patients was studied to determine any features that may diHeren-
`tiate the “sicca syndrome” from Sjogren’s syndrome.
`Furthermore, reduced Schirmer II tear tests may be demonstrated in a number of
`rheumatoid arthritic patients who have no evidence of punctatc or filamentary keratitis.
`For study purposes, these patients may be regarded as cases of “possible” Sjé')gren’s syn-
`drome. Lacrimal gland biopsies were obtained from a sample of patients with “possible”
`Sj<'3'gren’s syndrome in an attempt to elucidate the validity of this classification.
`According to Manschot (1961), systemic corticosteroids or adrenocorticotrophic hormone
`therapy may be efleetive in controlling acute exacerbations of Sj6gren’s syndrome and,
`therefore, may be expected to modify the histological appearances of the lacrimal gland.
`Thus particular note was taken of any history of systemic steroid therapy.
`
`Materials and methods
`
`PATIENTS STUDIED
`
`Biopsies of the lacrimal gland were obtained from 29 female patients (eighteen Sj6gren’s syndrome,
`five sicca syndrome, and six “possible” Sjogren’s syndrome).
`In addition, the lacrimal glands of
`
`Received for publication December 23. [972
`Address for reprints: J. Williamson, F.R.C.S., Eye Department, Southern General Hospital. Govan Road, Glasgow
`
`1
`
`ALL 2020
`MYLAN PHARMACEUTICALS V. ALLERGAN
`IPR2016-01128
`
`

`

`Keratoconjunctivitis sicca
`
`353
`
`ten age-matched patients, who had died from a variety of medical disorders not known to be related
`to rheumatoid arthritis or connective tissue disease and who had no history of ocular disease, were
`
`examined post mortem (Table I).
`
`Table I Ages ofpatients and controls and histology of lacrimal gland
`
`Clmical diagnosis
`
`Age (yrs)
`
`Histology (Stage)
`
`Number of patients mm mm
`Mean
`Range
`0
`I
`II
`III
`
`Sj6gren’s syndrome*
`Sicca syndrome'l‘**
`Possible Sj6gren’s syndrome
`
`18
`5
`6
`
`61 -4.
`61 -0
`60-2
`
`52-80
`55-81
`55—75
`
`8
`I — 9
`1
`— 2
`2
`6 — — —
`
`I 0
`
`64-0
`
`Controls
`Breast cancer (2)
`Coronary thrombosis (3)
`Cerebrovascular disease (5)
`
`
`32-76
`
`I 0 — ~ —
`
`* Two also had systemic lupus erythematosus
`‘I’ One had biliary cirrhosis
`** Three also had osteoarthritis
`
`The diagnosis of rheumatoid arthritis was based on the criteria of the American Rheumatism
`Association (Ropes, Bennett, Cobb, jacox, and Jessar, 1959).
`
`LACRIMAL GLAND BIOPSY TECHNIQUE
`
`Since removal of part of the palpebral portion of the lacrimal gland entails destruction of the excre-
`tory ducts, the orbital section was chosen for biopsy. Each patient understood the reason for the
`operation and that it was carried out on a voluntary basis. After infiltration with local anaesthesia,
`2 per cent. lignocaine without adrenaline, the skin was incised for a distance of I - 5 cm. from the lateral
`orbital tubercle towards the medical canthus, 0-5 cm. below and parallel to the superior orbital
`margin. Underlying fascia and muscle were separated by blunt dissection until the smoky-blue
`periorbital membrane was identified where it is closely attached to the rim of the orbit.
`Incision of
`the periorbital membrane resulted in protrusion of periorbital fat which was easily replaced with a
`probe. Toothed forceps were inserted into the superior lateral angle of the orbital roof and a piece
`of lacrimal gland tissue, no greater than I cu. mm., was abscised. The specimen was transported in
`formal saline. The skin wound was closed with three interrupted black silk sutures, no haemostatic
`
`or subcuticular stitches being necessary. Eyelid appearances returned to normal within 14 days
`and no complications were encountered. Histology was studied on paraffin sections 6 it thick
`stained by haematoxylin and eosin. Considerable care was taken to give the pathologist no infor-
`mation regarding the source of the lacrimal tissue.
`
`Results
`
`Table I shows the range of disorders from which the patients were suflering. Two of the
`24. rheumatoid arthritic patients also had systemic lupus erythematosus and three of the
`five “sicca syndrome” group also had osteoarthritis. There was no significant difference
`in the mean age and age range of the groups studied.
`
`Four distinct histological stages were recognized in this study (Table I):
`
`2
`
`

`

`854
`
`]o}zn Williamson, A. A. M. Gibson, T. Wilson, V. Forrester, K‘. Whale}, and W. C. Dick
`
`Stage 0 Normal lacrimal gland
`
`The lacrimal gland consists of tubulo-racemose tissue with short branched tubules and masses of
`lobules interspersed with fat (Fig. 1). Plasma cells are a normal feature of the interacinous and
`interlobular connective tissue; lymphocytes are less frequently detected.
`
`Stage 0.
`I
`FIG.
`Normal tissue.
`X 5
`
`Stage I
`
`.Mila' chronic inflammation
`
`The salient features in these cases are abnormal arrangement of the ducts, mild lymphocytic infil-
`tration, and slight intralobular fibrosis (Fig. 2).
`
`Stage I.
`FIG. 2
`Mild chronic in-
`
`flammation, showing
`abnormal duct
`
`arrangement.
`
`X 5
`
`3
`
`

`

`Keratoeonjunctivitis sicca
`
`855
`
`Stage II
`
`Severe chronic inflammation
`
`Total destruction of the normal lobular pattern, dense infiltration with lymphocytes, aggregating
`into lymph follicles and progressive acinar atrophy (Fig. 3) are the features of this grade.
`
`V
`
`n"'“:§.¢1¥*«:a'H...‘ 'u'»'.
`eff’ ‘fr ' or
`.
`.‘ 3*‘
`'
`W =.-:31"
`"
`'
`y
`3’
`
`4‘
`
`g:&,.’,.§.é',¢g
`
`Stage III Late fibrosis
`
`Fibrous tissue is increased. Few acinar cells remain (Fig. 4).
`
`Stage II.
`FIG. 3
`Severe chronic in-
`
`flammation.
`
`X 5
`
`Stage III.
`FIG. 4.
`Late fibrosix.
`X 5
`
`All of the ten post mortem control specimens and the six biopsies from patients suflering
`from “possible” Sj6gren’s syndrome showed normal lacrimal glands. Only one patient
`suffering from definite KCS had a normal tissue biopsy.
`Elk
`
`4
`
`

`

`856
`
`John Williamson, A. A. M. Gibson, T. I/Vilson, V. Forrester, K. IV/zaley, and I1’. C. Dick
`
`This patient was a 50-year-old woman with a 2-year history ofseropositive rheumatoid arthritis,
`xerostomia, and dry eyes. Her white blood count, serum globulin, and liver function tests were
`normal, the erythrocyte sedimentation rate being slightly raised to 25 mm. in the first hour. Tests
`for antinuclear factor and salivary duct antibody were negative and x-ray and functional grades were
`zero. All the evidence therefore indicated that the patient had mild chronic rheumatoid arthritis
`and KCS when the biopsy was taken.
`The remaining seventeen Sj(">gren’s syndrome and five sicca syndrome patients all
`showed abnormal lacrimal gland tissue (Table 1).
`Mild chronic inflammation (Stage I) was detected in one of the sicca syndrome patients
`who was also suffering from primary biliary cirrhosis.
`
`This was a 67-year-old wonnan with a 6-year history of liver disease without arthropathy and a
`6 months’ history of dry eyes. Salivary duct autoantibodies were present but there was no clinical,
`serological, or x-ray evidence of rheumatoid arthritis.
`
`The only other patient with mild chronic inflammation (Stage I) was a 75-year-old woman with
`a 6-year history of dry eyes and a dry mouth (sicca syndrome).
`
`Eleven patients, nine with Sjogren’s syndrome and two with the sicca syndrome, had
`severe chronic inflammatory changes (Stage II) and the late results of inflammation
`(Stage III) were recorded in the remaining nine patients, eight with Sjogren’s syndrome
`and one with sicca syndrome (Table II). No histological features distinguished the lacri-
`mal glands of patients with Sjo‘gren’s syndrome from those with the sicca syndrome.
`
`Table II Severity of lacrimal gland destruction
`related to duration of keratoconjunctivitix sicca
`
`N fl) t.
`t
`Duration of KCS
`Histology (Stages)
`a. o
`a zen s -
`9")
`0
`I
`11
`111
`
`4.
`4
`3
`4
`8
`
`0—I
`1-3
`3-5
`5-7
`7+
`
`Total 23
`
`3 —
`— 1
`I — 3 —
`— ~ — 3
`— I
`3 —
`— — 2
`6
`
`I
`
`2
`
`II
`
`9
`
`Severity of lacrimal gland destruction tended to be greater with increased duration of
`ocular disease (Table II). Thus none of the eight patients who had suffered from KCS
`for less than 3 years had Stage III changes. On the other hand, three patients with a
`3- to 5-year history showed only mild or severe chronic infiltration (Stages I and II).
`The groups are too small to compare with respect to severity of arthritis.
`Five of the patients with Sjogren’s syndrome had received steroid therapy for periods
`varying from 2 to 10 years in an average daily dose of 5 mg. prednisolone or its equivalent
`per day. Stage III (late) changes were described in four and Stage II (severe chronic) in one
`case. Steroid therapy had not prevented involvement of the lacrimal glands in these patients.
`All five patients had suffered from Sjogren’s syndrome for more than 5 years and had
`received systemic steroids during that
`time. Nevertheless, no difference in histology
`could be determined between these patients and the remaining group who had never
`received systemic steroids and who had also suffered from KCS for more than 5 years.
`
`5
`
`

`

`Keraloconjunctivitis sicca
`
`857
`
`Discussion
`
`Biopsy of the orbital portion of the lacrimal gland in patients suffering from KCS has not
`previously been recorded in a large series of patients. From our perusal of the literature,
`it appears that the lacrimal glands of no more than three patients have been examined
`post mortem in any one group, and in most instances only a single case has been reported.
`For these reasons, a series of 29 female patients depicting a range of involvement with
`KCS was selected for lacrimal gland biopsy. The specimens were classified into four stages:
`normal, mild chronic inflammation, severe chronic inflammation, and a late fibrotic
`phase.
`In general,
`the severity of destruction parallelled the duration of the ocular
`disease.
`
`Sjogren (1933), in discussing a patient who had suffered from KCS for 2 years, described
`chronic round cell infiltration around the excretory ducts and to a lesser extent in the inter-
`lobular and interacinous connective tissue. Secondary changes consisted of sclerosed
`connective tissue and degeneration in the epithelial cells near the infiltrated areas. Holm
`(1949), Ellman and others (1951), and Haas (1951) reported their findings in patients
`who had suffered from Sjogren’s syndrome for 6, 5, and 4 years respectively. Their des-
`criptions include destruction of the normal lobular pattern, infiltration with lymphocytes,
`and increase in fibrous tissue. Without examination of the sections, it is difficult to apply
`our classification to those specimens. However, the severity of lacrimal gland involvement
`in relation to the duration of the disease suggests that their findings are compatible with our
`Stages II and III.
`
`Furthermore, the investigation of two groups of three pateints was reported by Cardell
`and Gurling (1954) and Bloch and others (1965).
`The first authors described two female patients who had suffered from Sjogren’s syndrome for 4 and
`5 years respectively. Both had severe filamentary KCS and one also had polyarteritis nodosa.
`Both of those patients are relevant to this report in that they had been treated with ACTH and/or
`cortisone preparations. Nevertheless, the lacrimal glands contained areas densely infiltrated with
`chronic round cells, with some lymph follicle formation.
`Severe degeneration and atrophy of the
`parenchyma were widespread, as was replacement with fibro-adipose tissue. The specimens from
`these two patients could be classified as Stages II and III and, as in our series, the severity of the
`pathological changes seemed to have been unaffected by steroid therapy. Their third case was a
`
`man aged 73 years who had had KCS for 4 years without evidence of rheumatoid arthritis (sicca
`syndrome). Nevertheless, he had severe lacrimal gland destruction, obliterative endarteritis, and
`replacement of the normal glandular structure with fibro-adipose tissue. These findings substantiate
`our view that lacrimal gland changes are probably identical in both Sj6gren’s syndrome and KCS
`without evidence of connective tissue diseases.
`
`In our series the lacrimal glands of four patients with sicca syndrome were examined and
`no features were found to differentiate them from patients with Sj'o'gren’s syndrome.
`In the second group of three patients, Bloch and others (1965) described the pathology in the parotid
`gland of a 66-year-old woman who had suffered from Sj6gren’s syndrome for 11 years, and stated
`that the lacrimal gland changes were similar.
`They identified infiltration with small mononuclear cells and lymphocytes and noted that remnants
`of acinar components were sparse, located at the periphery of the lobules.
`Some of the ducts were
`distended with secretion, but the normal architecture of the lobules was preserved.
`It is interesting
`that they, like Cardell and Gurling, were able to identify occasional plasma cells.
`
`In our series plasma cells were not identified once lymphocytic infiltration had begun.
`
`The second case of Block and others (1965), a 49-year-old woman with progressive systemic
`sclerosis, had suffered from Sjogren’s syndrome for 14 years. The acinar atrophy was marked, and
`
`6
`
`

`

`858
`
`]ohn Williamson, A. A. M. Gibson, T. Wilson, ]. V. Forrester, K. Whaley, and W. C. Dick
`
`there was only slight lymphocytic infiltration. Replacement with fibro-adipose tissue was extensive.
`This description clearly falls into Stage III of the present series. Their third case was that of a
`68-year-old woman who had suffered from Sjogren’s syndrome for I year. The gland examined
`showed atrophy of acinar tissue and chronic inflammatory cell infiltration. Without more details,
`it is diflicult to identify the stage of involvement in this particular case.
`
`In our series, neither the ten age-matched patients examined post mortem, nor the six
`patients with “possible” Sjogren’s syndrome had abnormal lacrimal gland tissue. This
`would suggest that the definition of Sj6gren’s syndrome as a chronic inflammatory disease
`is valid, and it would appear from our biopsy findings that KCS without evidence of
`connective tissue disease is also a chronic inflammatory disorder. However, Radnot
`(1939) recorded over 30 years ago that patients over the age of 50 years undergo pro-
`gressive atrophy of the lacrimal glands and that infiltration with lymphocytes is a normal
`occurrence in this and older age groups. The mean age of the control group in this series
`was 64 years, yet no abnormalities of the lacrimal glands were detected.
`It would appear
`reasonable to suggest that more extensive examinations of “normal” lacrimal gland tissue,
`especially in older age groups, should be undertaken.
`
`Summary
`
`Histology of the lacrimal gland was studied in a series of 29 female patients, eighteen of
`whom had Sjogren’s syndrome, five the sicca syndrome, and six “possible” Sjogren’s
`syndrome. Furthermore, the lacrimal glands of ten patients with no history of ocular or
`connective tissue disease were examined post mortem.
`The appearances were classified into normal, mild chronic inflammation, severe chronic
`inflammation, and late fibrosis (Stages 0, I, II, and III). Both the controls and the
`“possible” cases of SJ'ogren’s syndrome had normal lacrimal glands. Those with Sjogren’s
`syndrome and the “sicca syndrome” showed abnormal
`lacrimal gland histology,
`the
`extent of which was related to the duration of the keratoconjunctivitis sicca. No specific
`features distinguished the lacrimal glands of Sj6gren’s syndrome from those of the sicca
`syndrome.
`In addition, long-term systemic steroid therapy did not seem to have reduced
`the extent of lacrimal gland pathology in the series examined.
`
`References
`
`ALLINGTON, H. v. (1950) Arch. Derm. Sy/2h., 62, 829
`BAIN, G. 0. (1960) Canad. mea'. Ass. j'., 82, 143
`
`BLOCH, K. J., BUCHANAN, w. w., WOHL, M. J., and BUNIM, J. J. (1965) Medicine (Baltimore), 44, 187
`BOHM, A. (1950) Miinch. med. Wschr., 92, 955
`BUCHER, U. G., and REID, L. (1959) Brit. ]. Dis. Chest, 53, 237
`CARDELL, B. s., and GURLING, K. J. (1954)
`j‘. Path. Bact., 68, 137
`ELLMAN, 12., WEBER, F. P., and GOODIER, T. E. w. (1951) Quart. ]. Med., 20, 33
`WUNATSU, H., and EGUCHI, F. J. (1957)
`clin. 0phthal., II (English Summary), 133
`HAAS, E. (1951)
`Virehows Arch. path. Anat., 320, 264
`HOLM, s. (1949) Acta ophlhal. (Kbh.), Suppl. 33, p. I
`MANSCHOT, w. A. (1961) Adv. 0phthal., n, I [Bibliotheca ophthalmologica Fasc. 58]
`MORGAN, A. D., and RAVEN, R. w. (1952) Brit. ]. Surg., 40, I54.
`RADNoT, M.
`(1939)
`“Die pathologische Histologie der Tranerdriise”, p. 64. Karger, Basel.
`Quoted by Holm (194.9)
`
`ROPES, M. w., BENNETT, G. A., coma, s., JAcox, R., and _]ESSAR, R. A. (1959) Ann. rheum. Dis., :8, 49
`sJ6GREN, H. (1933) Acta ophthal. (I{bh.), Suppl. 2.
`(Trans. J. B. Hamilton, 1943)
`SZANTO, L., FARKAS, K., and GYULAI, E. (1957) Rheumatism, I3, 60
`
`7
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket